Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone for miscarriage prevention in early pregnancy after subfertility
ACTRN12611000401954Phase 3Recruiting
- Sponsor
- Dr Luke McLindon
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Pregnancy loss comparing Progesterone pessary with Placebo pessary (2 arms). Primary endpoint: Miscarriage. Started Jan 2012; status: recruiting.
02
Drugs
progesterone
03
Conditions
Pregnancy loss
Beyond the preview
Go deeper on ACTRN12611000401954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000401954.